Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Trading Statement

20 Jan 2016 07:00

RNS Number : 2925M
Science in Sport PLC
20 January 2016
 

For immediate release

20 January 2016

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

Full Year Trading Update

 

Science in Sport plc (AIM: SIS), a leading sports nutrition company, is pleased to announce the following pre-close trading update ahead of its financial results for the 12 months ended 31 December 2015.

 

The Board is pleased to report another successful trading period during which sales continued to grow strongly and performance was in line with management expectations. Trading was very strong in the final quarter of the year and this momentum has carried into 2016.

 

Sales increased 18% to £9.45 million in the 12 months to 31 December 2015 compared with the same period the previous year (2014: £8.03 million).

 

Sales growth was particularly strong in international markets, from the Company's own online operation and from third-party e-tailers.

 

The first quarter of 2016 sees the launch and roll out of the Company's novel WHEY20 protein product, which will be distributed in approximately 1170 multiple grocer outlets by April. In addition approximately 400 independent cycle shops, High Street retailer Decathlon, and both Company and third-party e-commerce websites will sell the product.

 

The Company terminated its master distributor agreement with SiS Asia Pacific in December 2015, and has set up a wholly owned subsidiary to develop directly the SiS brand in the Australian market, managed by an in-market commercial team.

 

The Board remains confident of continued strong growth in 2016 and beyond.

 

SiS intends to issue its full year results on Tuesday 22 March 2016.

 

For further information:

 

Science in Sport PLC

+44 (0) 20 7400 3700

Stephen Moon, CEO

 

Cenkos Securities

 

+44 (0) 20 7397 8900

Bobbie Hilliam - NOMAD and Broker

 

Notes for editors

 

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community.

 

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars and hydration tablets; SiS REGO, including protein-based recovery powders and bars; and SiS Protein, a whey protein range for lean muscle development including WHEY20, a novel ready to consume whey protein product. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites. The Company sold product in more than 100 countries in 2015.

 

SiS is the official sports nutrition supplier to professional cycling teams Team Sky and Team WIGGINS. SiS is also the official supplier of sports drinks and sports nutrition to the GB Rowing Team. In addition, Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Katarina Johnson-Thompson are Elite Sports Consultants and brand ambassadors.

 

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

 

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

 

For further information, please visit www.scienceinsport.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGMMRLDGVZG
Date   Source Headline
30th Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSDirectorate Change
11th Aug 20229:00 amRNSPrice Monitoring Extension
25th Jul 20224:45 pmRNSBroker Update
8th Jul 202211:05 amRNSSecond Price Monitoring Extn
8th Jul 202211:00 amRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSHalf-Year Trading Update
15th Jun 20224:27 pmRNSResult of AGM
9th Jun 20227:00 amRNSBoard Change
12th May 202211:06 amRNSTR-1: Notification of Major Holdings
9th May 20227:00 amRNSNotice of AGM
5th May 202211:32 amRNSTR-1: Notification of Major Holdings
4th May 20227:00 amRNSPartnership With New York Marathon and NYRR
29th Apr 20227:00 amRNSGrant of Options, Adoption of New LTIP and TVR
28th Apr 20227:00 amRNSBreakthrough Sports Science Technology Study
21st Apr 20222:16 pmRNSTR-1: Notification of Major Holdings
8th Apr 20222:34 pmRNSTR-1: Notification of major holdings
8th Apr 20221:47 pmRNSTR-1: Notification of major holdings
29th Mar 20227:39 amRNSFinal Results
17th Mar 20227:00 amRNSInvestor Presentation
15th Mar 20227:00 amRNSDate of Final Results
10th Mar 20227:00 amRNSInvestor Presentation
22nd Feb 202211:27 amRNSTR-1: Notification of Major Holdings
22nd Feb 202211:24 amRNSTR-1: Notification of Major Holdings
24th Jan 20225:49 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSTrading Update
5th Jan 20227:00 amRNSAppointment of Joint Broker
4th Jan 20224:51 pmRNSHolding(s) in Company
7th Oct 20213:12 pmRNSHolding(s) in Company
29th Sep 20217:00 amRNSPartnership with Milwaukee Bucks
15th Sep 20217:00 amRNSInterim Results
9th Sep 20217:00 amRNSInvestor Presentation
2nd Aug 20217:00 amRNSNew PhD Nutrition 'Life' Range
19th Jul 20217:00 amRNSLaunch of new category-leading product range
14th Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20213:44 pmRNSResult of AGM
22nd Jun 20213:10 pmRNSHolding(s) in Company
21st Jun 202110:57 amRNSHolding(s) in Company
20th May 20217:00 amRNSNotice of AGM
19th May 202112:59 pmRNSNotification of Major Holdings
10th May 20215:10 pmRNSPDMR Share Purchases
10th May 20217:00 amRNSExtends Partnership with INEOS Grenadiers
28th Apr 202111:01 amRNSPDMR Share Purchases
18th Mar 20212:34 pmRNSNotification of Major Holdings
17th Mar 20217:00 amRNSFinal Results
11th Mar 20217:00 amRNSInvestor Presentation
5th Feb 202112:50 pmRNSNotification of Major Holdings
1st Feb 20211:59 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSCapital Markets Day
15th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.